Astellas Pharma India Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 33.69 Cr
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -31.32%
- Profit Growth -79.82%
- Ebitda -85.17%
- Net Worth 2.45%
- Total Assets 75.58%
About Astellas Pharma India
Astellas Pharma India Private Limited (APIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 14 November 2008 and has a history of 16 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 33.69 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Astellas Pharma India Private Limited India is Apurva Vinod as COMPANY SECRETARY. Mehmet Atay, Sampada Gosavi, and Ricardo Leite serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85192MH2008FTC188194
- Company No.
188194
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
14 Nov 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
What products or services does Astellas Pharma India Private Limited offer?
Astellas Pharma India Private Limited offers a wide range of products and services, including Sexual Wellness Products, Contraceptives, Common Disease Medicines, Steroid, Fertility Enhancer, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Astellas Pharma India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sampada Gosavi  | Managing Director | 24-Mar-2023 | Current |
| Apurva Vinod | Company Secretary | 28-Nov-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehmet Atay  | Director | 23-Jul-2020 | Current |
Ricardo Leite  | Additional Director | 07-Feb-2024 | Current |
Financial Performance of Astellas Pharma India.
Astellas Pharma India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.32% decrease. The company also saw a substantial fall in profitability, with a 79.82% decrease in profit. The company's net worth moved up by a moderate rise of 2.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astellas Pharma India?
In 2023, Astellas Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Astellas Pharma Capability Centre India Private Limited
Sampada Gosavi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Astellas Pharma India?
Astellas Pharma India has a workforce of 37 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astellas Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astellas Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Astellas Pharma India
Recent activity within the organization
- Annual General Meeting
Astellas Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Astellas Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Ricardo Fernando Bezerra Leite was appointed as a Additional Director was appointed as a Additional Director on 07 Feb 2024 & has been associated with this company since 1 year 1 month .
- Director Appointment
Sampada Anandkumar Gosavi was appointed as a Managing Director was appointed as a Managing Director on 24 Mar 2023 & has been associated with this company since 2 years 7 days .
- Director Appointment
Apurva Hemant Vinod was appointed as a Company Secretary was appointed as a Company Secretary on 28 Nov 2022 & has been associated with this company since 2 years 4 months .
- Director Appointment
Mehmet Alp Atay was appointed as a Director was appointed as a Director on 23 Jul 2020 & has been associated with this company since 4 years 8 months .
Recent News, Updates & Announcement
- Global Polio Vaccines Market 2018-2022: Cessation of Oral Polio Vaccine - Key Vendors are Astellas Pharma, GlaxoSmithKline, Sanofi Serum & Institute of India.
/PRNewswire/ -- The "Global Polio Vaccines Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Polio Vaccines Market to....
Frequently asked questions
What is the Incorporation or founding date of Astellas Pharma India Private Limited?
Astellas Pharma India Private Limited was incorporated on 14 Nov 2008.
What is authorized share capital and paid-up capital of Astellas Pharma India Private Limited?
The authorized share capital of Astellas Pharma India Private Limited is ₹ 50.00 Cr and paid-up capital is ₹ 33.69 Cr.
Who are the current board members & directors of Astellas Pharma India Private Limited?
Currently 4 directors are associated with Astellas Pharma India Private Limited.
- Mehmet Alp Atay
- Sampada Anandkumar Gosavi
- Ricardo Fernando Bezerra Leite
- Apurva Hemant Vinod
What is the registered address of Astellas Pharma India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Astellas Pharma India Private Limited is Unit No. 301 'C B Square' Cts 95 A 127 Andheri Kurla Rd Village Chakala, Andhe Ri (East) India, Mumbai, Maharashtra, 400069.
What is the corporate identification number (CIN) and company number of Astellas Pharma India Private Limited?
The corporate identification number (CIN) of Astellas Pharma India Private Limited is U85192MH2008FTC188194 and the company number is 188194 as per Ministry of Corporate Affairs (MCA).
What is the official website of Astellas Pharma India Private Limited?
The Official website of Astellas Pharma India Private Limited is https://www.astellas.com
What has been the recent revenue trend for Astellas Pharma India Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Astellas Pharma India Private Limited has fallen by -31.32%.
How many employees does Astellas Pharma India Private Limited currently have?
As Per 2023 financial reports, 37 employees are currently employed by Astellas Pharma India Private Limited.
What change has been observed in the net worth of Astellas Pharma India Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Astellas Pharma India Private Limited has experienced an upsurge of 2.45%.
When was the last Balance Sheet of Astellas Pharma India Private Limited filed with the ROC?
The most recent Balance Sheet for Astellas Pharma India Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Yasuhiro NakagiriDirector
Taichiro SeikeDirector
Mitsuru TadaDirector
Hiroshi HamaguchiDirectorAI
Akira IshidaDirectorMK
Michiaki KuriharaDirectorTY
Teruo YasufukuDirectorHY
Hidekazu YokoteDirector